Sign In
Buy IQV
$235.02
-2.80 (-1.18%)
At Close: Jul 31, 2026
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know
03:52pm, Sunday, 02'nd Aug 2026
The transaction involved the disposal of 558 shares at an exact weighted-average price of $245.21 per share on July 29, 2026. The sale reduced the insider's direct equity holdings by 16%, leaving 2,98
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know
03:42pm, Sunday, 02'nd Aug 2026
The transaction involved the sale of 5,000 shares at $249.16 per share, representing a total value of about $1.2 million. This disposition resulted in a 19% reduction of the insider total direct equit
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion
03:31pm, Sunday, 02'nd Aug 2026
The CEO of IQVIA executed an exercise-and-sell of stock appreciation rights involving shares at a weighted average price of $245.51 on July 29, 2026. Bousbib maintains substantial equity exposure thro
Amundi Has $148.20 Million Holdings in IQVIA Holdings Inc. $IQV
04:21am, Saturday, 01'st Aug 2026
Amundi lowered its holdings in shares of IQVIA Holdings Inc. (NYSE: IQV) by 19.2% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 869,003 shares of the medic
Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?
10:55am, Friday, 31'st Jul 2026
FHLC's 0.08% expense ratio and market-cap approach delivered stronger returns, while RSPH's equal-weight strategy offers lower volatility and broader diversification across 60 holdings.
IQVIA: A Great Business At The Wrong Price (Rating Downgrade)
09:59am, Wednesday, 29'th Jul 2026
IQVIA Holdings Inc. operates behind the scenes, running clinical trials and processing vast healthcare data for pharmaceutical companies. IQV's business spans clinical trial management, healthcare dat
IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31pm, Tuesday, 28'th Jul 2026
The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates an
IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript
04:23pm, Tuesday, 28'th Jul 2026
IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript
IQVIA Q2 Earnings Call Highlights
03:05pm, Tuesday, 28'th Jul 2026
IQVIA NYSE: IQV reported second-quarter results that exceeded the high end of its guidance, supported by accelerating organic revenue growth, higher R&D Solutions bookings and operational productivity
This Healthcare Stock Is Today's Best in the S&P 500
12:44pm, Tuesday, 28'th Jul 2026
IQVIA Holdings leads the index after the company boosted its full-year outlook on the back of a strong second quarter.
IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised
11:41am, Tuesday, 28'th Jul 2026
IQVIA's Q2 earnings beat estimates as record R&D bookings, broad-based growth and stronger demand support a raised 2026 outlook.
IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates
09:16am, Tuesday, 28'th Jul 2026
IQVIA Holdings (IQV) came out with quarterly earnings of $3.15 per share, beating the Zacks Consensus Estimate of $3.02 per share. This compares to earnings of $2.81 per share a year ago.
IQVIA raises annual profit forecast on clinical research demand
09:02am, Tuesday, 28'th Jul 2026
IQVIA Holdings raised its annual profit forecast on Tuesday after reporting better-than-expected second-quarter results, driven by strong demand for its healthcare data and analytics services, s
IQVIA Reports Second-Quarter 2026 Results
07:00am, Tuesday, 28'th Jul 2026
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to
Castleark Management LLC Makes New Investment in IQVIA Holdings Inc. $IQV
04:09am, Tuesday, 28'th Jul 2026
Castleark Management LLC bought a new position in IQVIA Holdings Inc. (NYSE: IQV) in the undefined quarter, according to its most recent disclosure with the SEC. The firm bought 22,580 shares of the m
